Larimar Therapeutics Correlations

LRMR Stock

USD 6.33 0.17 2.76%

The current 90-days correlation between Larimar Therapeutics and Sutro Biopharma is 0.35 (i.e., Weak diversification). The correlation of Larimar Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Larimar Therapeutics Correlation With Market

Modest diversification

The correlation between Larimar Therapeutics and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Larimar Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

To learn how to invest in Larimar Stock, please use our How to Invest in Larimar Therapeutics guide.

Moving against Larimar Stock

0.42	PG	Procter Gamble	Pair Corr
0.38	IBM	International Business Fiscal Year End 22nd of January 2025	Pair Corr
0.33	GE	GE Aerospace Fiscal Year End 28th of January 2025	Pair Corr
0.32	DD	Dupont De Nemours Fiscal Year End 4th of February 2025	Pair Corr

Related Correlations Analysis

	PCVX	SNDX	MRUS	STRO	IMRX	CNTA	CELC	IKNA	SPRO	BOLT
PCVX		0.06	0.18	-0.11	0.54	0.3	0.0	-0.33	0.05	-0.07	PCVX
SNDX	0.06		0.75	0.7	-0.31	-0.48	0.82	0.24	0.56	0.74	SNDX
MRUS	0.18	0.75		0.61	-0.21	-0.3	0.84	0.29	0.48	0.8	MRUS
STRO	-0.11	0.7	0.61		-0.59	-0.61	0.78	0.27	0.81	0.66	STRO
IMRX	0.54	-0.31	-0.21	-0.59		0.61	-0.41	-0.16	-0.29	-0.41	IMRX
CNTA	0.3	-0.48	-0.3	-0.61	0.61		-0.61	-0.02	-0.49	-0.6	CNTA
CELC	0.0	0.82	0.84	0.78	-0.41	-0.61		0.31	0.65	0.85	CELC
IKNA	-0.33	0.24	0.29	0.27	-0.16	-0.02	0.31		0.16	0.23	IKNA
SPRO	0.05	0.56	0.48	0.81	-0.29	-0.49	0.65	0.16		0.62	SPRO
BOLT	-0.07	0.74	0.8	0.66	-0.41	-0.6	0.85	0.23	0.62		BOLT
	PCVX	SNDX	MRUS	STRO	IMRX	CNTA	CELC	IKNA	SPRO	BOLT

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

BOLT	+ 0.85	CELC
CELC	+ 0.84	MRUS
CELC	+ 0.82	SNDX
SPRO	+ 0.81	STRO
BOLT	+ 0.8	MRUS
CELC	+ 0.78	STRO

High negative correlations

CELC	- 0.61	CNTA
CNTA	- 0.61	STRO
BOLT	- 0.6	CNTA
IMRX	- 0.59	STRO
SPRO	- 0.49	CNTA
CNTA	- 0.48	SNDX

Risk-Adjusted Indicators

There is a big difference between Larimar Stock performing well and Larimar Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Larimar Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
PCVX	2.18	0.41	0.07	(0.28)	2.19	(2.52)	3.16	(4.09)	42.81
SNDX	2.28	(0.56)	0.00	(0.11)	0.00	0.00	4.02	(4.33)	34.00
MRUS	1.67	(0.37)	0.00	(0.20)	0.00	0.00	3.08	(2.83)	10.85
STRO	3.48	(1.11)	0.00	(0.27)	0.00	0.00	8.38	(8.71)	30.73
IMRX	6.46	1.37	0.23	1.41	5.21	(9.02)	15.50	(8.68)	60.06
CNTA	3.02	0.43	0.13	0.47	3.06	(3.59)	8.37	(5.69)	21.09
CELC	2.20	(0.49)	0.00	(0.28)	0.00	0.00	4.02	(5.73)	16.97
IKNA	1.09	(0.07)	(0.07)	(0.01)	1.39	(1.50)	1.81	(1.74)	13.50
SPRO	1.78	(0.27)	0.00	(0.41)	0.00	0.00	3.79	(4.58)	14.92
BOLT	1.69	(0.25)	0.00	(2.95)	0.00	0.00	4.76	(4.48)	14.96

Larimar Therapeutics Corporate Management

Gopi MBA	Chief Officer	Profile
DO Sr	Chief Officer	Profile
Francis Conway	VP Controller	Profile
Sr DO	Chief Officer	Profile
John Berman	Vice Administration	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC